4th Developing CAPAs in the GCP Environment

 

2013 Event Summary – What you Missed

Were you not able to attend the 3rd Developing CAPAs in the GCP Environment Conference that took place on January 24-25, 2013? Click here to access a summary of the event highlighting the key takeaways. Don't miss our upcoming 4th Proactive GCP Compliance Conference, taking place April 10-12 in Washington DC, for more information go to www.exlpharma.com/gcp

 

ExL Pharma is pleased to offer the 4th Developing CAPAs in the GCP Environment Conference, taking place January 28-29 in Washington DC. As the only forum dedicated to clinical corrective and preventive actions, this event has become the annual gathering for clinical quality and operations professionals from companies of all sizes and types to discuss and share their experiences with understanding, defining, developing and implementing clinical CAPAs.

The 2014 event features numerous case studies detailing varying experiences with creating, integrating and applying company-wide clinical CAPA processes and systems. The event also offers half-day workshops, roundtable exercises and multiple panel discussions, providing ample time for interactivity, the sharing of experiences and brainstorming as the industry works together to identity and adopt efficient processes and systems.

TOP REASONS TO ATTEND

  • Attend the ONLY event dedicated to clinical CAPAs and benchmark your company’s clinical CAPA processes and systems against others of similar sizes and resources.
  • Learn from industry experts as they share practical case study presentations detailing varying steps of the clinical CAPA process, including identifying CAPA drivers, root cause analysis, system implementation, tools and technologies and measuring CAPA effectiveness.

Feedback from Previous Clinical CAPAs Conferences:

“One of the best conferences I have attended in my career” – Pfizer

“This was a great conference – surpassed my Expectations” – Polaris Compliance Consultants

“The event confirmed that I have been doing the right things from the start and now I have some great ideas on how to improve and take to the next level” – Kforce

“Enjoyed the details on CAPA concepts, systems and examples” – Genzyme

“This was a very good meeting for the first of it’s kind” – Boston Scientific

“Exceeded my expectations. I will attend again!” – Polaris Compliance Consultants

“I’m very happy with the information and presenters. Will recommend this conference” – P&G

“Great first meeting! Excellent speaker with a passion for compliance and improvement” – Regeneron

“I thoroughly enjoyed the conference. I’m excited to get back and share the valuable information with my group.” – GSK

Who Should Attend

C-Level, Vice President, Director, Manager and Team Leader level professionals from the following departments at Pharma/Biotech companies, Medical Device Companies, CROs and other Clinical Trial Service Providers:

  • Clinical Quality Assurance
  • Clinical Quality Control
  • Clinical Development
  • Clinical Operations
  • Quality Systems
  • GCP Compliance
  • Regulatory Compliance
  • Clinical Auditing
  • Clinical Monitoring

The conference also benefits:

  • Data Management and Computer Software Vendors
  • Quality Consultants
  • Investigative Sites